Out Of State Cog SCA denied as not FDA-approved for this use by Humana?

Humana's specific coverage criteria for out of state cog sca are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Out-of-State Cognitive/SCA Therapy as "Not FDA-Approved"

Rehabilitative and cognitive therapy services are not subject to FDA drug or device approval in the way that pharmaceuticals are. When Humana applies a "not FDA-approved" classification to out-of-state cognitive rehabilitation or spinocerebellar ataxia (SCA) therapy, it is typically relying on a policy provision that extends the experimental/investigational framework to services where it classifies the clinical evidence as insufficient — using "FDA-approved" language loosely to mean the specific protocol or program structure lacks regulatory or guideline endorsement. This category error is directly appealable.

## Why This Denial Is Appealable

Humana cannot legitimately deny a licensed rehabilitative health service solely because it lacks an FDA drug-approval equivalent — that standard simply does not apply to therapy services. The correct standard is whether the service is consistent with accepted medical practice for the condition. For SCA and complex cognitive rehabilitation, relevant specialty organizations in neurology and rehabilitation medicine provide practice frameworks that constitute accepted clinical standards, even absent FDA action. Your appeal should reframe the question from regulatory approval to accepted clinical practice.

Federal appeal rights: - ACA §2719 external review: Particularly valuable here — the external reviewer is a clinical specialist who can assess whether the treatment is accepted practice, independent of a misapplied regulatory framework. - ERISA §503: Requires Humana to specify the policy provision applied and the basis for the not-FDA-approved classification. - Timeline: Approximately 4 months from denial to request external review. Expedited review is available when delay would seriously harm your health.

## Appeal Process

1. Obtain the full denial identifying the specific policy provision and the meaning Humana assigns to "not FDA-approved" in this context. 2. Request clarification from Humana in writing: which FDA approval specifically is claimed to be missing, and what evidence standard it requires in lieu of FDA approval. 3. Have the treating neurologist write a letter explaining that the service is a licensed rehabilitative therapy consistent with applicable specialty guidelines, and that FDA drug-approval standards do not apply. 4. File internal appeal; escalate to external review with a clinician-specialist reviewer.

## Documentation to Gather

• Treating neurologist's letter addressing the regulatory framework error and affirming the treatment as consistent with accepted specialty practice
• Out-of-state program's description of its licensed, credentialed services and the clinical basis for the treatment approach
• Reference to the applicable specialty guideline organization (without citing specific statistics or cutoffs)
• Diagnosis and disease-progression records establishing why specialized treatment is required
• Humana's own policy language, marked where it misapplies an FDA-approval framework to a non-drug service

## Criteria-Mapping Structure

List each element of Humana's not-FDA-approved policy provision. For each element, provide the specific factual rebuttal: the service is a licensed therapy (not a drug or device); it is consistent with the applicable specialty guideline organization's recommendations; and it is delivered by credentialed licensed professionals. Address the evidentiary standard Humana actually requires and demonstrate the service meets it.